Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
Company Announcements

Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits

Armata Pharmaceuticals ( (ARMP) ) has shared an update.

Armata Pharmaceuticals, Inc. has announced the departure of its Vice President, Richard Rychlik, with the end of his employment slated for September 30, 2024. Rychlik will receive his base salary and subsidized health benefits until the end of the year as part of a Confidential Separation and Release Agreement, conditioned on his adherence to the agreement’s terms.

For detailed information about ARMP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskArmata Completes Enrollment for Innovative Bacteriophage Study
TheFlyArmata Pharmaceuticals completes enrollment of Phase 1b/2a diSArm study
Jason CarrARMP Earnings this Week: How Will it Perform?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App